Illumina Body Map 2 (GSE30611)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
FOSL2
|
ENSG00000075426.12 | FOS like 2, AP-1 transcription factor subunit |
SMARCC1
|
ENSG00000173473.11 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
FOSL2 | hg38_v1_chr2_+_28392802_28392866 | 0.60 | 2.7e-04 | Click! |
SMARCC1 | hg38_v1_chr3_-_47781837_47781908 | 0.34 | 5.4e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_+_73830988 | 10.14 |
ENST00000340958.4
|
CLDN4
|
claudin 4 |
chr22_+_22697789 | 9.60 |
ENST00000390306.2
|
IGLV2-23
|
immunoglobulin lambda variable 2-23 |
chr22_+_22758698 | 9.21 |
ENST00000390312.2
|
IGLV2-14
|
immunoglobulin lambda variable 2-14 |
chr22_+_22720615 | 8.88 |
ENST00000390309.2
|
IGLV3-19
|
immunoglobulin lambda variable 3-19 |
chr8_-_81483226 | 8.81 |
ENST00000256104.5
|
FABP4
|
fatty acid binding protein 4 |
chr2_+_89862438 | 8.34 |
ENST00000448155.2
|
IGKV1D-39
|
immunoglobulin kappa variable 1D-39 |
chr22_+_22822658 | 7.62 |
ENST00000620395.2
|
IGLV2-8
|
immunoglobulin lambda variable 2-8 |
chr2_+_89959979 | 7.22 |
ENST00000453166.2
|
IGKV2D-28
|
immunoglobulin kappa variable 2D-28 |
chr18_+_23873000 | 6.94 |
ENST00000269217.11
ENST00000587184.5 |
LAMA3
|
laminin subunit alpha 3 |
chr5_+_150640652 | 6.07 |
ENST00000307662.5
|
SYNPO
|
synaptopodin |
chr22_+_22369601 | 5.78 |
ENST00000390295.3
|
IGLV7-46
|
immunoglobulin lambda variable 7-46 |
chr7_+_30921430 | 5.41 |
ENST00000409899.5
ENST00000409611.1 |
AQP1
|
aquaporin 1 (Colton blood group) |
chr12_+_53098846 | 5.33 |
ENST00000650247.1
ENST00000549628.1 |
IGFBP6
|
insulin like growth factor binding protein 6 |
chr22_+_22734577 | 5.25 |
ENST00000390310.3
|
IGLV2-18
|
immunoglobulin lambda variable 2-18 |
chr17_-_41612757 | 5.21 |
ENST00000301653.9
ENST00000593067.1 |
KRT16
|
keratin 16 |
chr2_+_90100235 | 5.21 |
ENST00000492446.1
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16 |
chr1_+_156114700 | 4.93 |
ENST00000677389.1
ENST00000368300.9 ENST00000368299.7 |
LMNA
|
lamin A/C |
chr2_+_90159840 | 4.66 |
ENST00000377032.5
|
IGKV1D-12
|
immunoglobulin kappa variable 1D-12 |
chr22_+_22431949 | 4.56 |
ENST00000390301.3
|
IGLV1-36
|
immunoglobulin lambda variable 1-36 |
chr2_+_89851723 | 4.54 |
ENST00000429992.2
|
IGKV2D-40
|
immunoglobulin kappa variable 2D-40 |
chr22_+_22195753 | 4.50 |
ENST00000390285.4
|
IGLV6-57
|
immunoglobulin lambda variable 6-57 |
chr20_-_45827297 | 4.48 |
ENST00000372555.8
|
TNNC2
|
troponin C2, fast skeletal type |
chr10_+_17228806 | 4.27 |
ENST00000497849.1
|
VIM
|
vimentin |
chr2_+_90082635 | 4.23 |
ENST00000483379.1
|
IGKV1D-17
|
immunoglobulin kappa variable 1D-17 |
chr11_+_102112445 | 4.17 |
ENST00000524575.5
|
YAP1
|
Yes1 associated transcriptional regulator |
chr17_-_42423246 | 4.16 |
ENST00000357037.6
|
CAVIN1
|
caveolae associated protein 1 |
chr10_+_17228215 | 4.13 |
ENST00000544301.7
|
VIM
|
vimentin |
chr2_-_89320146 | 4.12 |
ENST00000498574.1
|
IGKV1-39
|
immunoglobulin kappa variable 1-39 |
chr22_+_22668286 | 4.10 |
ENST00000390304.2
|
IGLV3-27
|
immunoglobulin lambda variable 3-27 |
chr22_+_22214765 | 3.94 |
ENST00000390287.2
|
IGLV10-54
|
immunoglobulin lambda variable 10-54 |
chr10_+_17228515 | 3.86 |
ENST00000478746.1
|
VIM
|
vimentin |
chr2_-_89100352 | 3.70 |
ENST00000479981.1
|
IGKV1-16
|
immunoglobulin kappa variable 1-16 |
chr1_+_156114251 | 3.65 |
ENST00000361308.9
|
LMNA
|
lamin A/C |
chr11_-_57311456 | 3.56 |
ENST00000530920.1
|
TNKS1BP1
|
tankyrase 1 binding protein 1 |
chr1_+_223701582 | 3.54 |
ENST00000433674.6
|
CAPN2
|
calpain 2 |
chr11_-_6320494 | 3.32 |
ENST00000303927.4
ENST00000530979.1 |
CAVIN3
|
caveolae associated protein 3 |
chr22_+_22098683 | 3.25 |
ENST00000390283.2
|
IGLV8-61
|
immunoglobulin lambda variable 8-61 |
chr16_-_30113528 | 3.20 |
ENST00000406256.8
|
GDPD3
|
glycerophosphodiester phosphodiesterase domain containing 3 |
chr12_+_13196718 | 3.17 |
ENST00000431267.2
ENST00000542474.5 ENST00000544053.5 ENST00000256951.10 |
EMP1
|
epithelial membrane protein 1 |
chr14_-_106622837 | 3.16 |
ENST00000390628.3
|
IGHV1-58
|
immunoglobulin heavy variable 1-58 |
chr5_+_150640678 | 3.11 |
ENST00000519664.1
|
SYNPO
|
synaptopodin |
chr22_+_22792485 | 3.11 |
ENST00000390314.2
|
IGLV2-11
|
immunoglobulin lambda variable 2-11 |
chr22_+_22747383 | 3.05 |
ENST00000390311.3
|
IGLV3-16
|
immunoglobulin lambda variable 3-16 |
chr11_-_62689523 | 3.04 |
ENST00000317449.5
|
LRRN4CL
|
LRRN4 C-terminal like |
chr7_+_22727147 | 3.02 |
ENST00000426291.5
ENST00000401651.5 ENST00000258743.10 ENST00000407492.5 ENST00000401630.7 ENST00000406575.1 |
IL6
|
interleukin 6 |
chr1_-_43285559 | 2.96 |
ENST00000523677.6
|
C1orf210
|
chromosome 1 open reading frame 210 |
chr1_+_156126525 | 2.94 |
ENST00000504687.6
ENST00000473598.6 |
LMNA
|
lamin A/C |
chr3_+_36380477 | 2.90 |
ENST00000457375.6
ENST00000273183.8 ENST00000434649.1 |
STAC
|
SH3 and cysteine rich domain |
chr12_-_47758828 | 2.89 |
ENST00000389212.7
ENST00000449771.7 |
RAPGEF3
|
Rap guanine nucleotide exchange factor 3 |
chr2_+_89947508 | 2.88 |
ENST00000491977.1
|
IGKV2D-29
|
immunoglobulin kappa variable 2D-29 |
chr16_-_72620 | 2.87 |
ENST00000262316.10
|
RHBDF1
|
rhomboid 5 homolog 1 |
chr16_-_69726506 | 2.84 |
ENST00000561500.5
ENST00000320623.10 ENST00000439109.6 ENST00000564043.1 ENST00000379046.6 ENST00000379047.7 |
NQO1
|
NAD(P)H quinone dehydrogenase 1 |
chrX_-_155334580 | 2.84 |
ENST00000369449.7
ENST00000321926.4 |
CLIC2
|
chloride intracellular channel 2 |
chr4_+_73740541 | 2.83 |
ENST00000401931.1
ENST00000307407.8 |
CXCL8
|
C-X-C motif chemokine ligand 8 |
chr1_-_153549238 | 2.80 |
ENST00000368713.8
|
S100A3
|
S100 calcium binding protein A3 |
chr2_-_89160329 | 2.75 |
ENST00000390256.2
|
IGKV6-21
|
immunoglobulin kappa variable 6-21 (non-functional) |
chr20_+_46008900 | 2.74 |
ENST00000372330.3
|
MMP9
|
matrix metallopeptidase 9 |
chr22_+_22357739 | 2.73 |
ENST00000390294.2
|
IGLV1-47
|
immunoglobulin lambda variable 1-47 |
chr12_+_13196777 | 2.72 |
ENST00000538364.5
ENST00000396301.7 |
EMP1
|
epithelial membrane protein 1 |
chr2_+_89913982 | 2.70 |
ENST00000390265.2
|
IGKV1D-33
|
immunoglobulin kappa variable 1D-33 |
chr1_-_153549120 | 2.66 |
ENST00000368712.1
|
S100A3
|
S100 calcium binding protein A3 |
chr1_+_26863140 | 2.64 |
ENST00000339276.6
|
SFN
|
stratifin |
chr1_+_223701607 | 2.63 |
ENST00000434648.5
|
CAPN2
|
calpain 2 |
chr12_-_91179472 | 2.61 |
ENST00000550099.5
ENST00000546391.5 |
DCN
|
decorin |
chr2_-_89117844 | 2.55 |
ENST00000490686.1
|
IGKV1-17
|
immunoglobulin kappa variable 1-17 |
chr19_-_43670153 | 2.55 |
ENST00000601723.5
ENST00000339082.7 ENST00000340093.8 |
PLAUR
|
plasminogen activator, urokinase receptor |
chr6_+_44227025 | 2.54 |
ENST00000371708.1
|
SLC29A1
|
solute carrier family 29 member 1 (Augustine blood group) |
chr10_+_119651372 | 2.54 |
ENST00000369085.8
|
BAG3
|
BAG cochaperone 3 |
chr16_-_1230089 | 2.53 |
ENST00000612142.1
ENST00000606293.5 |
TPSB2
|
tryptase beta 2 |
chr1_-_151992571 | 2.53 |
ENST00000368809.1
|
S100A10
|
S100 calcium binding protein A10 |
chr11_-_102798148 | 2.51 |
ENST00000315274.7
|
MMP1
|
matrix metallopeptidase 1 |
chr22_+_22380766 | 2.50 |
ENST00000390297.3
|
IGLV1-44
|
immunoglobulin lambda variable 1-44 |
chr13_+_101489940 | 2.49 |
ENST00000376162.7
|
ITGBL1
|
integrin subunit beta like 1 |
chr11_-_111923722 | 2.48 |
ENST00000527950.5
|
CRYAB
|
crystallin alpha B |
chr17_-_15263162 | 2.47 |
ENST00000674673.1
ENST00000675950.1 |
PMP22
|
peripheral myelin protein 22 |
chr6_+_41637005 | 2.44 |
ENST00000419164.6
ENST00000373051.6 |
MDFI
|
MyoD family inhibitor |
chr12_-_91179355 | 2.44 |
ENST00000550563.5
ENST00000546370.5 |
DCN
|
decorin |
chr6_-_31736504 | 2.42 |
ENST00000616760.1
ENST00000375784.7 ENST00000375779.6 |
CLIC1
|
chloride intracellular channel 1 |
chr2_-_89213917 | 2.42 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
chr2_+_90021567 | 2.41 |
ENST00000436451.2
|
IGKV6D-21
|
immunoglobulin kappa variable 6D-21 (non-functional) |
chr22_+_22395005 | 2.40 |
ENST00000390298.2
|
IGLV7-43
|
immunoglobulin lambda variable 7-43 |
chr1_-_156705575 | 2.38 |
ENST00000368222.8
|
CRABP2
|
cellular retinoic acid binding protein 2 |
chr5_-_150155828 | 2.38 |
ENST00000261799.9
|
PDGFRB
|
platelet derived growth factor receptor beta |
chr3_-_12158901 | 2.35 |
ENST00000287814.5
|
TIMP4
|
TIMP metallopeptidase inhibitor 4 |
chrX_+_100644183 | 2.32 |
ENST00000640889.1
ENST00000373004.5 |
SRPX2
|
sushi repeat containing protein X-linked 2 |
chr1_+_183186238 | 2.30 |
ENST00000493293.5
ENST00000264144.5 |
LAMC2
|
laminin subunit gamma 2 |
chr16_+_1240698 | 2.26 |
ENST00000561736.2
ENST00000338844.8 ENST00000461509.6 |
TPSAB1
|
tryptase alpha/beta 1 |
chr7_+_94394886 | 2.25 |
ENST00000297268.11
ENST00000620463.1 |
COL1A2
|
collagen type I alpha 2 chain |
chr9_-_107489754 | 2.23 |
ENST00000610832.1
ENST00000374672.5 |
KLF4
|
Kruppel like factor 4 |
chr1_+_156126160 | 2.22 |
ENST00000448611.6
ENST00000368297.5 |
LMNA
|
lamin A/C |
chr2_+_169509693 | 2.20 |
ENST00000284669.2
|
KLHL41
|
kelch like family member 41 |
chr19_+_48874318 | 2.19 |
ENST00000600406.1
|
PPP1R15A
|
protein phosphatase 1 regulatory subunit 15A |
chr3_-_149377637 | 2.19 |
ENST00000305366.8
|
TM4SF1
|
transmembrane 4 L six family member 1 |
chr22_+_22375984 | 2.18 |
ENST00000390296.2
|
IGLV5-45
|
immunoglobulin lambda variable 5-45 |
chr2_-_89040745 | 2.16 |
ENST00000480492.1
|
IGKV1-12
|
immunoglobulin kappa variable 1-12 |
chr12_+_47758958 | 2.15 |
ENST00000549243.5
|
SLC48A1
|
solute carrier family 48 member 1 |
chr11_-_111913195 | 2.15 |
ENST00000531198.5
ENST00000616970.5 ENST00000527899.6 |
CRYAB
|
crystallin alpha B |
chr6_-_73520170 | 2.14 |
ENST00000678508.1
|
EEF1A1
|
eukaryotic translation elongation factor 1 alpha 1 |
chr10_+_102395693 | 2.13 |
ENST00000652277.1
ENST00000189444.11 ENST00000661543.1 |
NFKB2
|
nuclear factor kappa B subunit 2 |
chr10_-_44385043 | 2.13 |
ENST00000374426.6
ENST00000395794.2 ENST00000374429.6 ENST00000395793.7 ENST00000343575.10 ENST00000395795.5 |
CXCL12
|
C-X-C motif chemokine ligand 12 |
chr1_-_153565535 | 2.12 |
ENST00000368707.5
|
S100A2
|
S100 calcium binding protein A2 |
chr12_+_2959296 | 2.12 |
ENST00000358409.7
ENST00000359864.8 ENST00000540314.2 ENST00000536826.2 |
TEAD4
|
TEA domain transcription factor 4 |
chr6_+_130366281 | 2.09 |
ENST00000617887.4
|
TMEM200A
|
transmembrane protein 200A |
chr9_-_35685462 | 2.08 |
ENST00000607559.1
|
TPM2
|
tropomyosin 2 |
chr4_+_168832005 | 2.07 |
ENST00000393726.7
ENST00000507735.6 |
PALLD
|
palladin, cytoskeletal associated protein |
chr17_-_41586887 | 2.06 |
ENST00000167586.7
|
KRT14
|
keratin 14 |
chr13_-_41019289 | 2.04 |
ENST00000239882.7
|
ELF1
|
E74 like ETS transcription factor 1 |
chr12_+_2959870 | 2.03 |
ENST00000397122.6
|
TEAD4
|
TEA domain transcription factor 4 |
chr11_-_102874974 | 2.03 |
ENST00000571244.3
|
MMP12
|
matrix metallopeptidase 12 |
chr2_+_47369301 | 2.02 |
ENST00000263735.9
|
EPCAM
|
epithelial cell adhesion molecule |
chr21_-_26843012 | 2.01 |
ENST00000517777.6
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif 1 |
chr21_-_26843063 | 2.00 |
ENST00000678221.1
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif 1 |
chr19_-_46625037 | 2.00 |
ENST00000596260.1
ENST00000594275.1 ENST00000597185.1 ENST00000598865.5 ENST00000291294.7 |
PTGIR
|
prostaglandin I2 receptor |
chr11_-_111913134 | 1.97 |
ENST00000533971.2
ENST00000526180.6 |
CRYAB
|
crystallin alpha B |
chr11_+_10305065 | 1.96 |
ENST00000534464.1
ENST00000278175.10 ENST00000530439.1 ENST00000524948.5 ENST00000528655.5 ENST00000526492.4 ENST00000525063.2 |
ADM
|
adrenomedullin |
chr22_+_22030934 | 1.96 |
ENST00000390282.2
|
IGLV4-69
|
immunoglobulin lambda variable 4-69 |
chr8_+_103372388 | 1.94 |
ENST00000520337.1
|
CTHRC1
|
collagen triple helix repeat containing 1 |
chr6_-_73520441 | 1.92 |
ENST00000615060.5
|
EEF1A1
|
eukaryotic translation elongation factor 1 alpha 1 |
chr8_+_125430333 | 1.92 |
ENST00000311922.4
|
TRIB1
|
tribbles pseudokinase 1 |
chr8_+_86098901 | 1.91 |
ENST00000285393.4
|
ATP6V0D2
|
ATPase H+ transporting V0 subunit d2 |
chr9_-_127578989 | 1.91 |
ENST00000373314.7
|
NIBAN2
|
niban apoptosis regulator 2 |
chr1_+_36156096 | 1.88 |
ENST00000474796.2
ENST00000373150.8 ENST00000373151.6 |
MAP7D1
|
MAP7 domain containing 1 |
chr19_-_35501878 | 1.88 |
ENST00000593342.5
ENST00000601650.1 ENST00000408915.6 |
DMKN
|
dermokine |
chr8_+_69563824 | 1.86 |
ENST00000525999.5
|
SULF1
|
sulfatase 1 |
chr20_+_35172046 | 1.85 |
ENST00000216968.5
|
PROCR
|
protein C receptor |
chr3_+_11137093 | 1.84 |
ENST00000438284.2
|
HRH1
|
histamine receptor H1 |
chr2_+_119431846 | 1.84 |
ENST00000306406.5
|
TMEM37
|
transmembrane protein 37 |
chr12_-_76084666 | 1.83 |
ENST00000393263.7
ENST00000548044.5 ENST00000547704.5 ENST00000618691.5 ENST00000431879.7 ENST00000549596.5 ENST00000550934.5 ENST00000551600.5 ENST00000547479.5 ENST00000547773.5 ENST00000544816.5 ENST00000542344.5 ENST00000548273.5 |
NAP1L1
|
nucleosome assembly protein 1 like 1 |
chr6_+_73695779 | 1.82 |
ENST00000422508.6
ENST00000437994.6 |
CD109
|
CD109 molecule |
chrX_+_136169624 | 1.79 |
ENST00000394153.6
|
FHL1
|
four and a half LIM domains 1 |
chr12_-_76084612 | 1.79 |
ENST00000535020.6
ENST00000552342.5 |
NAP1L1
|
nucleosome assembly protein 1 like 1 |
chr1_-_43285606 | 1.79 |
ENST00000423420.1
|
C1orf210
|
chromosome 1 open reading frame 210 |
chr3_+_30606574 | 1.77 |
ENST00000295754.10
ENST00000359013.4 |
TGFBR2
|
transforming growth factor beta receptor 2 |
chr3_+_191329342 | 1.76 |
ENST00000392455.9
|
CCDC50
|
coiled-coil domain containing 50 |
chr11_+_394196 | 1.75 |
ENST00000331563.7
ENST00000531857.1 |
PKP3
|
plakophilin 3 |
chr12_-_91179517 | 1.74 |
ENST00000551354.1
|
DCN
|
decorin |
chr11_-_65900413 | 1.74 |
ENST00000448083.6
ENST00000531493.5 ENST00000532401.1 |
FOSL1
|
FOS like 1, AP-1 transcription factor subunit |
chr12_-_55842950 | 1.73 |
ENST00000548629.5
|
MMP19
|
matrix metallopeptidase 19 |
chr11_-_111379268 | 1.73 |
ENST00000393067.8
|
POU2AF1
|
POU class 2 homeobox associating factor 1 |
chr12_-_55728994 | 1.73 |
ENST00000257857.9
|
CD63
|
CD63 molecule |
chr5_-_150155627 | 1.73 |
ENST00000517488.1
|
PDGFRB
|
platelet derived growth factor receptor beta |
chr11_-_10568571 | 1.73 |
ENST00000529598.1
|
LYVE1
|
lymphatic vessel endothelial hyaluronan receptor 1 |
chr11_+_67583742 | 1.72 |
ENST00000398603.6
|
GSTP1
|
glutathione S-transferase pi 1 |
chr1_-_6602859 | 1.72 |
ENST00000377658.8
|
KLHL21
|
kelch like family member 21 |
chrX_+_116436599 | 1.72 |
ENST00000598581.3
|
SLC6A14
|
solute carrier family 6 member 14 |
chr3_-_100114488 | 1.71 |
ENST00000477258.2
ENST00000354552.7 ENST00000331335.9 ENST00000398326.2 |
FILIP1L
|
filamin A interacting protein 1 like |
chr12_-_55707865 | 1.70 |
ENST00000347027.10
ENST00000257879.11 ENST00000553804.6 |
ITGA7
|
integrin subunit alpha 7 |
chrX_-_49043345 | 1.68 |
ENST00000315869.8
|
TFE3
|
transcription factor binding to IGHM enhancer 3 |
chr1_-_6602885 | 1.67 |
ENST00000377663.3
|
KLHL21
|
kelch like family member 21 |
chr11_+_67583803 | 1.67 |
ENST00000398606.10
|
GSTP1
|
glutathione S-transferase pi 1 |
chr6_+_130365958 | 1.67 |
ENST00000296978.4
|
TMEM200A
|
transmembrane protein 200A |
chr3_+_48466222 | 1.66 |
ENST00000625293.3
ENST00000492235.2 ENST00000635452.2 ENST00000456089.1 |
TREX1
|
three prime repair exonuclease 1 |
chr9_-_127122623 | 1.65 |
ENST00000373417.1
ENST00000373425.8 |
ANGPTL2
|
angiopoietin like 2 |
chr19_-_40425982 | 1.65 |
ENST00000357949.5
|
SERTAD1
|
SERTA domain containing 1 |
chr15_+_40844018 | 1.65 |
ENST00000344051.8
ENST00000562057.6 |
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
chr15_+_88638947 | 1.64 |
ENST00000559876.2
|
ISG20
|
interferon stimulated exonuclease gene 20 |
chr5_-_76623391 | 1.63 |
ENST00000296641.5
ENST00000504899.1 |
F2RL2
|
coagulation factor II thrombin receptor like 2 |
chr11_-_76669985 | 1.63 |
ENST00000407242.6
ENST00000421973.1 |
LRRC32
|
leucine rich repeat containing 32 |
chr1_-_223665685 | 1.63 |
ENST00000366872.10
|
CAPN8
|
calpain 8 |
chr15_+_67128103 | 1.63 |
ENST00000558894.5
|
SMAD3
|
SMAD family member 3 |
chr17_+_7579491 | 1.62 |
ENST00000380498.10
ENST00000584502.1 ENST00000250092.11 |
CD68
|
CD68 molecule |
chr3_+_191329020 | 1.61 |
ENST00000392456.4
|
CCDC50
|
coiled-coil domain containing 50 |
chr19_-_43780957 | 1.60 |
ENST00000648319.1
|
KCNN4
|
potassium calcium-activated channel subfamily N member 4 |
chr20_+_37383648 | 1.60 |
ENST00000373567.6
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase |
chr12_-_55728977 | 1.58 |
ENST00000552164.5
|
CD63
|
CD63 molecule |
chrX_+_136169664 | 1.56 |
ENST00000456445.5
|
FHL1
|
four and a half LIM domains 1 |
chr5_-_141682192 | 1.54 |
ENST00000508305.5
|
ARAP3
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 |
chr16_-_53052849 | 1.53 |
ENST00000619363.2
|
ENSG00000277639.2
|
novel protein |
chrX_+_136169833 | 1.52 |
ENST00000628032.2
|
FHL1
|
four and a half LIM domains 1 |
chr17_-_1486124 | 1.52 |
ENST00000575158.5
|
MYO1C
|
myosin IC |
chr5_-_141682211 | 1.52 |
ENST00000239440.9
|
ARAP3
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 |
chr12_-_57520480 | 1.52 |
ENST00000642841.1
ENST00000547303.5 ENST00000552740.5 ENST00000547526.1 ENST00000346473.8 ENST00000551116.5 |
ENSG00000285133.1
DDIT3
|
novel protein DNA damage inducible transcript 3 |
chr7_-_108003122 | 1.48 |
ENST00000393559.2
ENST00000222399.11 ENST00000676777.1 ENST00000439976.6 ENST00000393560.5 ENST00000677793.1 ENST00000679244.1 |
LAMB1
|
laminin subunit beta 1 |
chrX_+_49171918 | 1.48 |
ENST00000376322.7
|
PLP2
|
proteolipid protein 2 |
chr6_+_33075952 | 1.47 |
ENST00000418931.7
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1 |
chr12_+_2959791 | 1.46 |
ENST00000543035.6
|
TEAD4
|
TEA domain transcription factor 4 |
chrX_+_136169891 | 1.46 |
ENST00000449474.5
|
FHL1
|
four and a half LIM domains 1 |
chr11_-_10568650 | 1.46 |
ENST00000256178.8
|
LYVE1
|
lymphatic vessel endothelial hyaluronan receptor 1 |
chr15_-_21742799 | 1.45 |
ENST00000622410.2
|
ENSG00000278263.2
|
novel protein, identical to IGHV4-4 |
chr1_-_12616762 | 1.43 |
ENST00000464917.5
|
DHRS3
|
dehydrogenase/reductase 3 |
chr6_+_73696145 | 1.42 |
ENST00000287097.6
|
CD109
|
CD109 molecule |
chr17_-_18258556 | 1.41 |
ENST00000579294.5
ENST00000628188.1 ENST00000545457.6 ENST00000578558.5 ENST00000327031.9 |
FLII
|
FLII actin remodeling protein |
chrX_+_49171889 | 1.41 |
ENST00000376327.6
|
PLP2
|
proteolipid protein 2 |
chr11_-_75490725 | 1.41 |
ENST00000529721.5
|
GDPD5
|
glycerophosphodiester phosphodiesterase domain containing 5 |
chr2_+_47369467 | 1.41 |
ENST00000419334.1
|
EPCAM
|
epithelial cell adhesion molecule |
chr10_+_24466487 | 1.40 |
ENST00000396446.5
ENST00000396445.5 ENST00000376451.4 |
KIAA1217
|
KIAA1217 |
chr19_+_38304105 | 1.39 |
ENST00000588605.5
ENST00000301246.10 |
C19orf33
|
chromosome 19 open reading frame 33 |
chr5_-_141651376 | 1.39 |
ENST00000522783.5
ENST00000519800.1 ENST00000435817.7 |
FCHSD1
|
FCH and double SH3 domains 1 |
chr5_-_177497561 | 1.39 |
ENST00000359895.6
ENST00000355572.6 ENST00000393551.5 ENST00000505074.5 ENST00000393546.8 ENST00000355841.7 |
PDLIM7
|
PDZ and LIM domain 7 |
chr17_-_1485733 | 1.38 |
ENST00000648446.1
|
MYO1C
|
myosin IC |
chr16_+_1256059 | 1.37 |
ENST00000397534.6
ENST00000211076.5 |
TPSD1
|
tryptase delta 1 |
chr2_+_102104563 | 1.36 |
ENST00000409589.5
ENST00000409329.5 |
IL1R1
|
interleukin 1 receptor type 1 |
chr2_-_89297785 | 1.36 |
ENST00000465170.1
|
IGKV1-37
|
immunoglobulin kappa variable 1-37 (non-functional) |
chr11_-_67374168 | 1.36 |
ENST00000533438.1
|
CLCF1
|
cardiotrophin like cytokine factor 1 |
chr19_+_13731744 | 1.35 |
ENST00000586600.5
|
CCDC130
|
coiled-coil domain containing 130 |
chr2_+_36696686 | 1.35 |
ENST00000379242.7
ENST00000389975.7 |
VIT
|
vitrin |
chr19_-_43781249 | 1.34 |
ENST00000615047.4
|
KCNN4
|
potassium calcium-activated channel subfamily N member 4 |
chr5_-_135578983 | 1.34 |
ENST00000512158.6
|
CXCL14
|
C-X-C motif chemokine ligand 14 |
chr20_+_44715360 | 1.34 |
ENST00000190983.5
|
CCN5
|
cellular communication network factor 5 |
chr22_+_22771791 | 1.34 |
ENST00000390313.3
|
IGLV3-12
|
immunoglobulin lambda variable 3-12 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 13.7 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
1.8 | 5.4 | GO:0035378 | carbon dioxide transmembrane transport(GO:0035378) |
1.5 | 8.9 | GO:0098886 | modification of dendritic spine(GO:0098886) |
1.4 | 4.1 | GO:0060981 | cell migration involved in coronary angiogenesis(GO:0060981) |
1.1 | 3.4 | GO:0035732 | nitric oxide storage(GO:0035732) |
1.1 | 3.3 | GO:0043465 | fermentation(GO:0006113) regulation of fermentation(GO:0043465) |
1.0 | 3.9 | GO:0035853 | chromosome passenger complex localization to spindle midzone(GO:0035853) |
0.9 | 4.5 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.8 | 3.0 | GO:1990637 | response to prolactin(GO:1990637) |
0.7 | 3.0 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.7 | 2.9 | GO:0006117 | acetaldehyde metabolic process(GO:0006117) |
0.7 | 3.3 | GO:0014740 | negative regulation of muscle hyperplasia(GO:0014740) |
0.6 | 12.3 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.6 | 1.9 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.6 | 98.9 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.6 | 1.8 | GO:2000563 | bronchus morphogenesis(GO:0060434) positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
0.6 | 1.8 | GO:1901388 | regulation of transforming growth factor beta activation(GO:1901388) negative regulation of transforming growth factor beta activation(GO:1901389) |
0.5 | 2.2 | GO:1902310 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.5 | 2.1 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.5 | 2.1 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
0.5 | 8.8 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.5 | 2.4 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.5 | 1.4 | GO:1902905 | positive regulation of fibril organization(GO:1902905) |
0.5 | 3.6 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.4 | 1.3 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) regulation of dendritic cell dendrite assembly(GO:2000547) |
0.4 | 2.5 | GO:0015862 | uridine transport(GO:0015862) |
0.4 | 1.2 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.4 | 5.3 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.4 | 2.8 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.4 | 7.1 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.4 | 7.0 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.4 | 2.6 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.4 | 12.4 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.4 | 1.1 | GO:1903465 | vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
0.4 | 1.1 | GO:2000452 | CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
0.4 | 13.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.3 | 2.8 | GO:0007296 | vitellogenesis(GO:0007296) |
0.3 | 3.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.3 | 2.3 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.3 | 1.3 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.3 | 2.9 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.3 | 1.0 | GO:0035425 | autocrine signaling(GO:0035425) |
0.3 | 2.9 | GO:0002159 | desmosome assembly(GO:0002159) |
0.3 | 4.7 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
0.3 | 1.9 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.3 | 6.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 | 1.8 | GO:0097325 | melanocyte proliferation(GO:0097325) |
0.3 | 1.5 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.3 | 5.9 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.3 | 5.9 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.3 | 3.1 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.3 | 0.9 | GO:0036323 | vascular endothelial growth factor receptor-1 signaling pathway(GO:0036323) |
0.3 | 6.4 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.3 | 1.9 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.3 | 1.3 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.3 | 2.9 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.3 | 2.4 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.3 | 8.4 | GO:0032060 | bleb assembly(GO:0032060) |
0.3 | 2.8 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
0.3 | 2.1 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.3 | 3.5 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.2 | 0.7 | GO:0070295 | renal water absorption(GO:0070295) |
0.2 | 1.2 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.2 | 0.9 | GO:0052360 | multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
0.2 | 1.4 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
0.2 | 49.6 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.2 | 1.8 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.2 | 3.5 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.2 | 3.6 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.2 | 0.6 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.2 | 0.8 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 1.0 | GO:2000863 | negative regulation of macrophage chemotaxis(GO:0010760) positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
0.2 | 0.8 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
0.2 | 0.8 | GO:0061055 | myotome development(GO:0061055) |
0.2 | 1.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 0.6 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.2 | 4.6 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.2 | 0.9 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.2 | 2.0 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.2 | 0.5 | GO:0007518 | myoblast fate determination(GO:0007518) |
0.2 | 2.5 | GO:0046541 | saliva secretion(GO:0046541) |
0.2 | 0.5 | GO:0042946 | glucoside transport(GO:0042946) |
0.2 | 3.4 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.2 | 2.2 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.2 | 0.5 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
0.2 | 1.0 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.2 | 1.9 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.2 | 2.6 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.2 | 2.8 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.2 | 3.1 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.2 | 2.6 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.2 | 1.2 | GO:0015793 | glycerol transport(GO:0015793) |
0.2 | 3.2 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.2 | 1.1 | GO:0030421 | defecation(GO:0030421) |
0.1 | 1.0 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 0.7 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 6.1 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 0.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.9 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 2.0 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.6 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 2.4 | GO:0046449 | creatinine metabolic process(GO:0046449) |
0.1 | 1.8 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 1.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 3.3 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 3.6 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.8 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.1 | 0.4 | GO:0046108 | uridine metabolic process(GO:0046108) |
0.1 | 0.4 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
0.1 | 2.5 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.1 | 0.8 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.1 | 0.7 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 1.0 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 0.5 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.1 | 1.1 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 1.0 | GO:0051414 | response to cortisol(GO:0051414) |
0.1 | 0.4 | GO:0006043 | glucosamine catabolic process(GO:0006043) |
0.1 | 0.7 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.1 | 0.6 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
0.1 | 0.3 | GO:0051097 | negative regulation of helicase activity(GO:0051097) oligodendrocyte apoptotic process(GO:0097252) |
0.1 | 0.8 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.1 | 1.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 2.0 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 0.8 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.1 | 0.7 | GO:0060356 | leucine import(GO:0060356) |
0.1 | 0.8 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 1.2 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 1.1 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.1 | 0.3 | GO:1902173 | negative regulation of keratinocyte apoptotic process(GO:1902173) |
0.1 | 1.8 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.6 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 2.0 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.6 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 5.5 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.4 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.1 | 0.4 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.1 | 0.9 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 1.7 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 1.7 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 3.4 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.1 | 4.2 | GO:0009303 | termination of RNA polymerase I transcription(GO:0006363) rRNA transcription(GO:0009303) |
0.1 | 3.6 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
0.1 | 0.2 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
0.1 | 2.2 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 1.4 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.1 | 0.8 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) |
0.1 | 0.5 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.1 | 0.8 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.1 | 0.9 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 0.5 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.1 | 0.3 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.1 | 0.4 | GO:1900040 | membrane to membrane docking(GO:0022614) regulation of interleukin-2 secretion(GO:1900040) negative regulation of interleukin-2 secretion(GO:1900041) terminal web assembly(GO:1902896) |
0.1 | 1.2 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.8 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.1 | 1.9 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.1 | 0.4 | GO:0021817 | nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) |
0.1 | 0.5 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.1 | 0.4 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 2.5 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.1 | 5.1 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 0.4 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.1 | 0.7 | GO:0032887 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
0.1 | 1.1 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.1 | 0.5 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 1.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.6 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.1 | 0.7 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 5.7 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
0.1 | 1.4 | GO:0040034 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.1 | 0.9 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.1 | 0.2 | GO:0042245 | RNA repair(GO:0042245) |
0.1 | 1.1 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.1 | 3.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 1.4 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.3 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
0.1 | 0.1 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.1 | 0.7 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 1.3 | GO:0044849 | estrous cycle(GO:0044849) |
0.1 | 0.5 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.4 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 0.6 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.2 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) negative regulation of bicellular tight junction assembly(GO:1903347) |
0.1 | 0.4 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.5 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.9 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.1 | 0.7 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.4 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.1 | 0.7 | GO:1903543 | positive regulation of exosomal secretion(GO:1903543) |
0.0 | 1.9 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.0 | 1.4 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.5 | GO:2000582 | regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.0 | 1.3 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.0 | 0.4 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.0 | 0.1 | GO:0015734 | taurine transport(GO:0015734) |
0.0 | 0.2 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.0 | 1.0 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.0 | 2.0 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 3.0 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.0 | 0.2 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
0.0 | 1.9 | GO:0006298 | mismatch repair(GO:0006298) |
0.0 | 0.1 | GO:0070904 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.0 | 0.6 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.2 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.0 | 1.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.1 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.0 | 5.5 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.0 | 0.7 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.0 | 0.1 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.0 | 3.1 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.0 | 0.9 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.6 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 0.8 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.0 | 0.2 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.0 | 0.8 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
0.0 | 1.2 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.0 | 1.5 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.0 | 0.9 | GO:0051412 | response to corticosterone(GO:0051412) |
0.0 | 2.5 | GO:0070527 | platelet aggregation(GO:0070527) |
0.0 | 0.4 | GO:0010524 | positive regulation of calcium ion transport into cytosol(GO:0010524) |
0.0 | 0.1 | GO:1901374 | acetate ester transport(GO:1901374) |
0.0 | 0.4 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.0 | 0.9 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.0 | 0.4 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.0 | 0.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 0.8 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.0 | 0.2 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.0 | 0.4 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.1 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.0 | 0.5 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.2 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.0 | 0.9 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.0 | 0.1 | GO:0039516 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
0.0 | 0.5 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.0 | 0.3 | GO:0010626 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) Schwann cell proliferation(GO:0014010) |
0.0 | 0.5 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.0 | 0.8 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.0 | 0.2 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.0 | 0.3 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.0 | 0.2 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.0 | 0.5 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.5 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.0 | 0.1 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 | 0.9 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.5 | GO:0045730 | respiratory burst(GO:0045730) |
0.0 | 0.3 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.1 | GO:0071105 | response to interleukin-11(GO:0071105) cellular response to interleukin-11(GO:0071348) |
0.0 | 0.1 | GO:0033131 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.0 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.5 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.1 | GO:0098758 | interleukin-8-mediated signaling pathway(GO:0038112) response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
0.0 | 0.8 | GO:0043535 | regulation of blood vessel endothelial cell migration(GO:0043535) |
0.0 | 0.5 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 2.1 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.0 | 3.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.6 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 2.2 | GO:0051225 | spindle assembly(GO:0051225) |
0.0 | 0.3 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.0 | 0.1 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.0 | 0.2 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.2 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.0 | 0.2 | GO:0032329 | serine transport(GO:0032329) |
0.0 | 0.0 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.0 | 0.1 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.0 | 0.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.2 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.1 | GO:0030728 | ovulation(GO:0030728) |
0.0 | 0.6 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 9.2 | GO:0097444 | spine apparatus(GO:0097444) |
1.8 | 5.4 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
1.2 | 13.7 | GO:0005638 | lamin filament(GO:0005638) |
0.8 | 3.4 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.8 | 4.2 | GO:0071149 | TEAD-1-YAP complex(GO:0071148) TEAD-2-YAP complex(GO:0071149) |
0.8 | 7.7 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.8 | 3.8 | GO:0043256 | laminin complex(GO:0043256) |
0.7 | 2.2 | GO:0005584 | collagen type I trimer(GO:0005584) |
0.7 | 2.9 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
0.6 | 1.8 | GO:1990917 | sperm head plasma membrane(GO:1990913) ooplasm(GO:1990917) |
0.6 | 2.9 | GO:0045160 | myosin I complex(GO:0045160) |
0.6 | 1.7 | GO:0044753 | amphisome(GO:0044753) |
0.5 | 2.1 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.5 | 6.8 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.5 | 1.5 | GO:1990622 | CHOP-ATF4 complex(GO:1990617) CHOP-ATF3 complex(GO:1990622) |
0.4 | 3.9 | GO:0005827 | polar microtubule(GO:0005827) |
0.4 | 6.6 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.4 | 5.3 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.4 | 16.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 1.2 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
0.3 | 8.3 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.3 | 3.5 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.3 | 4.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.3 | 1.7 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 4.6 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.3 | 3.6 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.3 | 1.4 | GO:0097059 | CRLF-CLCF1 complex(GO:0097058) CNTFR-CLCF1 complex(GO:0097059) |
0.3 | 4.5 | GO:0005861 | troponin complex(GO:0005861) |
0.2 | 1.8 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.2 | 4.4 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 0.7 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.2 | 1.0 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.2 | 1.1 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.2 | 0.9 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.2 | 0.9 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 4.5 | GO:0097342 | ripoptosome(GO:0097342) |
0.2 | 1.1 | GO:0001652 | granular component(GO:0001652) |
0.1 | 1.7 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 2.1 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 0.7 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
0.1 | 5.7 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 1.4 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 3.6 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 0.4 | GO:0035517 | PR-DUB complex(GO:0035517) |
0.1 | 1.9 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 26.4 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.3 | GO:1905103 | integral component of lysosomal membrane(GO:1905103) |
0.1 | 1.9 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 1.0 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.5 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.1 | 0.5 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.1 | 0.4 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.1 | 2.0 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.8 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 2.7 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.1 | 3.3 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 1.5 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.5 | GO:0032010 | phagolysosome(GO:0032010) |
0.1 | 14.6 | GO:0005882 | intermediate filament(GO:0005882) |
0.1 | 9.6 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 4.2 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 0.4 | GO:0097513 | myosin II filament(GO:0097513) |
0.1 | 0.8 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.5 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 2.2 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 2.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.7 | GO:0055028 | cortical microtubule(GO:0055028) |
0.1 | 6.1 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.1 | 0.5 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.1 | 1.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 1.5 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 5.8 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 1.5 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 3.7 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.4 | GO:0060171 | stereocilium membrane(GO:0060171) |
0.1 | 0.5 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.0 | 0.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 6.2 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.2 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
0.0 | 1.0 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 1.5 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.4 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.0 | 0.7 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 3.1 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 1.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 1.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.6 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 2.9 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 1.7 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 2.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 5.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.2 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 4.8 | GO:0005903 | brush border(GO:0005903) |
0.0 | 0.2 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 1.0 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.6 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.1 | GO:0036398 | TCR signalosome(GO:0036398) |
0.0 | 3.9 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 2.8 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 52.0 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 1.8 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 2.3 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 1.6 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.7 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 1.0 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 1.2 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 5.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 2.3 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 1.4 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.1 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 1.2 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 9.2 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 0.2 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.5 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.0 | 0.4 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.2 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.5 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.0 | 1.3 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 1.1 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 54.3 | GO:0005576 | extracellular region(GO:0005576) |
0.0 | 1.7 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 1.4 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 5.8 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 1.4 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 1.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 5.4 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
1.8 | 14.3 | GO:1990254 | keratin filament binding(GO:1990254) |
1.1 | 3.4 | GO:0035730 | S-nitrosoglutathione binding(GO:0035730) dinitrosyl-iron complex binding(GO:0035731) |
1.0 | 4.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
1.0 | 4.1 | GO:0005019 | platelet-derived growth factor beta-receptor activity(GO:0005019) |
1.0 | 3.0 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.9 | 2.8 | GO:0003955 | NAD(P)H dehydrogenase (quinone) activity(GO:0003955) |
0.7 | 2.6 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.6 | 1.8 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.6 | 6.5 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.6 | 1.8 | GO:0002135 | CTP binding(GO:0002135) |
0.6 | 152.3 | GO:0003823 | antigen binding(GO:0003823) |
0.5 | 1.4 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.5 | 3.6 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.4 | 1.3 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.4 | 2.5 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
0.4 | 5.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.4 | 2.2 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.4 | 5.8 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.4 | 1.1 | GO:0005199 | structural constituent of cell wall(GO:0005199) |
0.3 | 0.9 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
0.3 | 3.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.3 | 1.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.3 | 2.3 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.3 | 1.5 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.3 | 0.9 | GO:0036327 | VEGF-A-activated receptor activity(GO:0036326) VEGF-B-activated receptor activity(GO:0036327) placental growth factor-activated receptor activity(GO:0036332) |
0.3 | 1.4 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.3 | 1.9 | GO:0042806 | fucose binding(GO:0042806) |
0.2 | 10.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 1.9 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.2 | 1.9 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.2 | 7.0 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.2 | 1.4 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.2 | 1.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.2 | 0.8 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.2 | 0.5 | GO:0042947 | glucoside transmembrane transporter activity(GO:0042947) |
0.2 | 1.2 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.2 | 1.4 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.2 | 2.5 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.2 | 1.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 0.6 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
0.2 | 7.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 1.9 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.2 | 1.7 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 2.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.2 | 6.7 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.1 | 1.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.9 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.1 | 1.6 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 2.9 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 1.9 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 0.5 | GO:0032427 | GBD domain binding(GO:0032427) |
0.1 | 1.6 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 2.2 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 2.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 1.0 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 1.0 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.1 | 0.4 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.1 | 0.4 | GO:0098918 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
0.1 | 4.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.4 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
0.1 | 0.6 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
0.1 | 0.6 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
0.1 | 0.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 1.3 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 4.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 1.1 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.1 | 0.4 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.1 | 1.9 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 5.1 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 6.9 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 0.4 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 18.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.5 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.1 | 0.5 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.1 | 3.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 2.7 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 2.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 2.8 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 0.5 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 0.2 | GO:0090541 | MIT domain binding(GO:0090541) |
0.1 | 1.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 3.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 8.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 1.5 | GO:0043522 | cAMP response element binding protein binding(GO:0008140) leucine zipper domain binding(GO:0043522) |
0.1 | 1.7 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 1.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 2.5 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 3.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.7 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.6 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.1 | 0.5 | GO:0004471 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.1 | 0.5 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 5.3 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 2.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.9 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 1.5 | GO:0016918 | retinal binding(GO:0016918) |
0.1 | 1.3 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.2 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
0.1 | 1.0 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.1 | 0.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 1.9 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.7 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 1.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 2.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.4 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.5 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.5 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.1 | GO:0047225 | acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0047225) |
0.0 | 1.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.0 | 0.4 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 1.1 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.0 | 0.2 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.0 | 0.7 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 1.7 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 1.0 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 1.9 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.1 | GO:0005368 | taurine transmembrane transporter activity(GO:0005368) taurine:sodium symporter activity(GO:0005369) |
0.0 | 0.1 | GO:0070984 | SET domain binding(GO:0070984) |
0.0 | 0.9 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.0 | 1.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.7 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.0 | 1.2 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.5 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.0 | 0.3 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 1.2 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 0.1 | GO:0015229 | L-ascorbate:sodium symporter activity(GO:0008520) nucleobase transmembrane transporter activity(GO:0015205) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.0 | 0.7 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 1.0 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.9 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.5 | GO:0042731 | PH domain binding(GO:0042731) |
0.0 | 0.1 | GO:0005277 | acetylcholine transmembrane transporter activity(GO:0005277) secondary active organic cation transmembrane transporter activity(GO:0008513) acetate ester transmembrane transporter activity(GO:1901375) |
0.0 | 1.0 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.7 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 1.1 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 2.4 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.8 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.8 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.5 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 0.7 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 6.6 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.1 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.0 | 0.4 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.0 | 1.5 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.6 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.6 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.3 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.0 | 12.6 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 3.2 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 1.8 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.2 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.0 | 4.7 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.3 | GO:0001163 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.0 | 0.3 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.0 | 25.3 | GO:0005198 | structural molecule activity(GO:0005198) |
0.0 | 0.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 5.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.6 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.2 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.4 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.4 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.4 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.1 | GO:0015322 | proton-dependent oligopeptide secondary active transmembrane transporter activity(GO:0005427) secondary active oligopeptide transmembrane transporter activity(GO:0015322) |
0.0 | 0.6 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.0 | 0.7 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.4 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.0 | 0.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.2 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.0 | 0.6 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.7 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 1.6 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.0 | 3.2 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.0 | 0.4 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.6 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 8.7 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.1 | GO:0043273 | CTPase activity(GO:0043273) |
0.0 | 0.1 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.0 | 0.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 0.4 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 1.8 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.0 | 0.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.6 | GO:0008536 | Ran GTPase binding(GO:0008536) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 12.6 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.4 | 26.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 27.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 6.3 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 13.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 5.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 3.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 2.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 10.5 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 1.8 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 4.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 2.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 1.6 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 3.2 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 3.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 3.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 3.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 3.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 6.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 6.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 2.3 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 6.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 1.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 1.3 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 1.9 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 3.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 5.8 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 1.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 3.0 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.9 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.6 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 1.6 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 2.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 1.8 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 1.9 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.3 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 8.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.8 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 1.8 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.7 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.7 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.9 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.4 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 2.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 5.2 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 6.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.3 | 7.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.3 | 11.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.3 | 2.8 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.3 | 4.8 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.3 | 6.8 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 11.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 9.0 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 15.1 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.2 | 9.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 5.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 6.3 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.2 | 2.0 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 2.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 14.1 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 5.4 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 1.9 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 2.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 3.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 3.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 2.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 1.6 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 1.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 1.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 0.4 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 6.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 2.1 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 5.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 1.5 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 1.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 2.9 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 3.0 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 0.9 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 2.5 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 1.6 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 0.5 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 2.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 2.7 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 2.8 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 1.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 1.0 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 2.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 1.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.3 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 4.4 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 1.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 4.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 1.2 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.7 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 1.0 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 3.9 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 1.4 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.7 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.8 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 1.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 2.0 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 4.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.7 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 1.3 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.6 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.6 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 0.6 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.5 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 1.8 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 1.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.5 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.4 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.0 | 0.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.5 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.4 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.2 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |